Medicine information
Uses & overview
VOGLISLOW G3 M 0.3 is a triple-combination oral antidiabetic formulation marketed by Steris Healthcare. It combines Voglibose 0.3 mg, Glimepiride 3 mg, and Metformin Hydrochloride 500 mg to support blood glucose control in adults with type 2 diabetes mellitus when prescribed by a qualified healthcare professional. Each ingredient works through a different mechanism: Voglibose 0.3 mg: An alpha-glucosidase inhibitor that slows carbohydrate digestion and absorption in the intestine, helping manage post-meal blood glucose levels. Glimepiride 3 mg: A sulfonylurea that stimulates insulin release from the pancreas to help lower blood glucose. Metformin Hydrochloride 500 mg: Helps reduce glucose production in the liver and improves the body's response to insulin. The combination may be prescribed when multiple medicines are needed to achieve individualized blood glucose targets. Treatment should be supported by a balanced diet, regular physical activity, and routine blood glucose monitoring. VOGLISLOW G3 M 0.3 should be used only as directed by a doctor. The appropriate dosage and treatment plan depend on the patient's medical history, kidney and liver function, blood glucose levels, and response to therapy.
How to use
Take VOGLISLOW G3 M 0.3 exactly as prescribed by your doctor. Follow the dosage and meal-related instructions provided by your healthcare professional and the product packaging. Voglibose is generally taken immediately before meals; however, the timing of this combination tablet should follow the approved product instructions. Swallow the tablet with water as directed. Do not change the prescribed dose or stop treatment without consulting your doctor. Maintain your recommended meal plan, exercise regularly, and monitor blood glucose as advised. If you miss a meal or experience symptoms of low blood sugar, follow your healthcare professional's guidance. Contact your doctor if you experience repeated hypoglycaemia, persistent gastrointestinal discomfort, or other unexpected side effects.
Storage
Store VOGLISLOW G3 M 0.3 according to the instructions printed on the product packaging. Keep the tablets in their original packaging and protect them from excessive heat, moisture, and direct sunlight. Keep the medicine out of the reach of children. Do not use the tablets after their expiry date. Dispose of unused or expired medicines responsibly according to local pharmaceutical disposal guidance.
